Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer Using Clinical Histopathological and Biological Markers

NCT03121768 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03121768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03121768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer Using Clinical Histopathological and Biological Markers
Lead sponsor
Mansoura University
Phase
Observational
Overall status
Unknown status
Start date
May 15, 2017
Completion date
April 1, 2022
Enrollment
761 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcg, bladder cancer, oncology, progression, recurrence, superficial bladder cancer